Awardee: Charles Hoffman
Institution: Boston College
Award Amount: $68,185
Funding Period: February 1, 2019 - January 31, 2020
Identification and characterization of novel cell-permeable, small molecule adenylyl cyclase inhibitors for future development as drugs to treat FD/MAS
Previous
Previous
Single cell transcriptome analysis of skeletal stem cells derived from FD/MAS patients
Next
Next